Lyrica Capsules 150 mg (Pregabalin)

Adult dose

This medication is administered orally, divided into two doses per day, regardless of food intake. 1. Neuropathic Pain - Peripheral Neuropathic Pain: Starting dose of 150 mg per day, can be increased to 300 mg per day after 3 to 7 days, if necessary, can further increase to a maximum of 600 mg at intervals of 7 days. - Central Neuropathic Pain: Starting dose of 150 mg per day, increase to 300 mg per day after one week.

Child dose

Safety and efficacy data for children under 12 years and adolescents aged 12 to 17 years are insufficient; therefore, administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors, so if mood changes or depressive symptoms occur during treatment, consult a healthcare professional immediately. Do not take this medication if you are allergic to any of its components, and it should not be given to patients with certain genetic problems, such as lactose intolerance. For diabetic patients, weight gain may affect blood sugar control, so dosage adjustments for hypoglycemic agents may be necessary. If allergic reactions such as angioedema occur, discontinue the medication immediately and inform a healthcare professional. Elderly patients should be cautious as dizziness or drowsiness may increase the risk of falls or accidents, especially at the beginning of treatment. Consult a healthcare professional if you experience blurred vision or changes in eyesight. Sudden discontinuation of this medication may lead to withdrawal symptoms such as insomnia, headache, and anxiety; therefore, dosage should be gradually reduced according to a healthcare professional's instructions. Patients with a history of substance abuse should be particularly cautious as there is a higher potential for misuse and dependence on this medication. Patients with impaired renal function may require dosage adjustments, and those with heart conditions should be carefully evaluated before use. Taking this medication with opioid analgesics can increase central nervous system depressant effects, raising the risk of respiratory depression. In early pregnancy, the risk of congenital defects in the fetus may be present, so pregnant women should avoid this medication, and women of childbearing age should use effective contraception. During breastfeeding, this medication can be passed into breast milk, and its safety for infants has not been established, so consideration should be given to discontinuing breastfeeding or the medication. Be cautious while performing hazardous activities like driving or operating machinery, as dizziness or drowsiness may occur due to this medication. In case of overdose, confusion, drowsiness, depression, seizures, etc., may occur; immediate emergency treatment is necessary, and blood dialysis may be performed if needed. Store in a safe place out of reach of children, and do not transfer the medication to other containers.

Serious side effects

Hives, severe swelling (angioedema), difficulty breathing, cold sweat, severe allergic reactions, severe rash with fever, blisters, skin peeling, pain of oral/ocular mucous membranes, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), profound lethargy, liver changes (jaundice), sudden and severe headaches, lightning headaches, seizures

Mild side effects

• Dizziness
• drowsiness
• confusion
• impaired coordination
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. Additionally, it is recommended to store the medication at a temperature between 15 degrees and 30 degrees, avoiding extremes of heat or cold.

Appearance

A hard capsule with a white or pale yellow powder inside, with the upper and lower parts being white.

Package unit

30 capsules/bottle, 100 capsules/bottle